SUNREST — Sunrest Lifescience Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹287.51m
- IN₹526.42m
- IN₹708.33m
Annual cashflow statement for Sunrest Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10.5 | 27.4 | 5.93 | 26.2 | 101 |
| Depreciation | |||||
| Non-Cash Items | -0.116 | 0.591 | 2.18 | 3.05 | -7.28 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -15.5 | -17.8 | -157 | -1.02 | -106 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.49 | 11.5 | -148 | 29.2 | -0.5 |
| Capital Expenditures | -4.67 | -0.142 | -0.071 | -13.7 | -75.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.1 | -0.165 | 0 | 2.27 | 46 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -3.56 | -0.307 | -0.071 | -11.4 | -29.1 |
| Financing Cash Flow Items | -0.108 | -0.591 | -2.18 | -3.04 | -14.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.12 | -11.5 | 146 | -3.27 | 39.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.07 | -0.301 | -1.6 | 14.5 | 10.3 |